Showing results (111-120 of 143) with videos related to

Sort By:
Pageof 15
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 14, 2000
Atypical effect of minoxidil sulphate on guinea pig airwaysK H Buchheit, A Hofmann, P Manley, et al.
Journal of Cardiovascular Pharmacology|January 1, 1988
Similarities in the mechanism of action of two new vasodilator drugs: pinacidil and BRL 34915N S Cook, U Quast, R P Hof, et al.
European Journal of Biochemistry|April 1, 1975
Kinetics of binding of bovine trypsin-killikrein inhibitor (K unitz) in which the reactive-site peptide bond Lys-15--Ala-16 is cleaved, to alpha-chymotrypsin and beta-trypsinU Quast, J Engel, E Steffen, et al.
European Journal of Biochemistry|April 1, 1975
The effect of cleaving the reactive-site peptide bond Lys-15--Ala-16 on the conformation of bovine trypsin-kallikrein inhibitor (K unitz) as revealed by solvent-perturbation spectra, circular dichroism and fluorescenceU Quast, J Engel, E Steffen, et al.
British Journal of Pharmacology|August 22, 2006
KATP channel openers of the benzopyran type reach their binding site via the cytosolD Stephan, E Salamon, H Weber, et al.
Wiener Medizinische Wochenschrift (1946)|January 1, 1997
[Oral vaccines against poliomyelitis and vaccination-related paralytic poliomyelitis in Germany. Do we need a new immunization strategy?]R Fescharek, C Arras-Reiter, E R Arens, et al.
Developments in Biological Standardization|October 1, 1976
Freeze-drying of a purified human diploid cell rabies vaccineM Majer, A Herrmann, J Hilfenhaus, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1987
Na+ channels as sites of action of the cardioactive agent DPI 201-106 with agonist and antagonist enantiomersG Romey, U Quast, D Pauron, et al.
European Journal of Pharmacology|August 14, 1992
Analysis of the relaxant action of SDZ PCO 400 in airway smooth muscle from the ox and guinea-pigR C Small, J L Berry, R W Foster, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 1, 1985
DPI 201-106, a novel cardioactive agent. Combination of cAMP-independent positive inotropic, negative chronotropic, action potential prolonging and coronary dilatory propertiesG Scholtysik, R Salzmann, R Berthold, et al.
Pageof 15